psmarketresearch.com
25.07.2023, 12:43:41
The revenue generated by the pharmacogenomics industry will power at a 7.4% rate by the end of this decade, to reach USD 10,505.3 million by 2030. The industry growth is because of the growing incidence of infectious diseases and various cancers, increasing acceptance of personalized medicine, a shift from reaction to prevention globally, increasing rate of opposing drug reactions, and growing use of pharmacogenomics in medicine discovery and development.
Сохранено в Healthcare Trends
Здоровье
The revenue generated by the pharmacogenomics industry will power at a 7.4% rate by the end of this decade, to reach USD 10,505.3 million by 2030.
The industry growth is because of the growing incidence of infectious diseases and various cancers, increasing acceptance of personalized medicine, a shift from reaction to prevention globally, increasing rate of opposing drug reactions, and growing use of pharmacogenomics in medicine discovery and development.